- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0000901

About Central Drug House Private Ltd
Data last updated:
Central Drug House Private Ltd is a private limited company based in New Delhi, Delhi, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 06 March 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1985PTC020363. Its GSTIN is 07AAACC2523P1ZN (Delhi). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹13 Cr. It is led by directors including Saurabh Aggarwal and Sachin Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7/28 Vardaan Housansari Road Darygang, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.12 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹10.36 Cr (net margin 20.3%) and EBITDA of ₹14.16 Cr (EBITDA margin 27.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 15% over five years.
The company has about 65 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹90.27 Lakh and satisfied charges of ₹19.96 Lakh on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Cr; the latest was in March 2025. Its 3 peer companies in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger; the largest is Ecmas Construction Chemicals Private Limited with revenue of ₹51.89 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2024, listing 188 overdue payments to 97 micro and small suppliers.
Central Drug House Private Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0000901). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cdhfinechemical.com.
Company details
Recognitions & Rankings of Central Drug House
Contact details
Central Drug House Private Ltd's registered office is in New Delhi, Delhi. Its website is cdhfinechemical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address7/28 Vardaan Housansari Road Darygang, New Delhi, Delhi, India – 110002
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Central Drug House Private Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Central Drug House is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Central Drug House Private Ltd, buy the company report.
Financials of Central Drug House Private Ltd
FY 2025 filings availableCentral Drug House Private Ltd reported revenue of ₹51.12 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 9% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.36 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.7% | ||||
| Net Profit Margin | 20.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Central Drug House Private Ltd, buy the company report.
Board of directors of Central Drug House Private Ltd
Central Drug House has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Aggarwal Also directs: Himicro Laboratories Private Limited | Director | 10 Feb 2012 | 14 Years 9 Months | Current |
| Sachin Aggarwal Also directs: Himicro Laboratories Private Limited | Director | 05 May 2010 | 16 Years 6 Months | Current |
| Shankar Lal Aggarwal Also directs: Himicro Laboratories Private Limited | Director | 16 Mar 1985 | 41 Years 8 Months | Current |
Peer comparison
Central Drug House Private Ltd is compared with the 3 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ecmas Construction Chemicals Private Limited | ₹51.89 Cr (FY 2025) | 27.0% | Hyderabad, Telangana, India | |||
| Tarak Chemicals Limited | ₹51.81 Cr (FY 2025) | 9.0% | Vadodara, Gujarat, India | |||
| Galata Chemicals India Private Limited | ₹51.66 Cr (FY 2024) | 51.0% | Mumbai, Maharashtra, India | |||
| Central Drug House Private Ltdthis company | ₹51.12 Cr (FY 2025) | ₹10.36 Cr | 20.3% | 9.0% | New Delhi, Delhi, India |
To see the full peer comparison of Central Drug House Private Ltd, buy the company report.
Auditor
Central Drug House Private Ltd is audited by SNR & Company for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SNR & Company | FY 2025 | 014401N |
Shareholding
The shareholding of Central Drug House Private Ltd is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Central Drug House Private Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2025 | 101110602 | Hdfc Bank Limited | ₹80.3 Lakh | Open | |
| 23 Jul 2021 | 100479069 | Hdfc Bank Limited | ₹9.97 Lakh | Open | |
| 19 Jun 2023 | 100738877 | Others | ₹18 Lakh | Satisfied | |
| 17 Oct 2005 | 90331116 | Sundaram Finance Ltd. | ₹1.96 Lakh | Satisfied |
To see the full charge records of Central Drug House Private Ltd, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Central Drug House Private Ltd has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Cr; the latest was in March 2025.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Dec 2012 | Funding round | ₹11.5 Cr | Investors: 3 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Shankar Lal Aggarwal HUF, 3 individuals |
| Jun 2010 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Central Drug House Private Ltd has 5 court cases on record: 4 filed by Central Drug House, 1 filed against it. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
| District courts | 2 | 1 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Civil suit | Filed against the company by Thomson Press (India) Ltd. | Disposed |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| High Court of Delhi | Court case (CO.PET.) | Filed by the company | Disposed |
| Bombay High Court | Court case (CHS) | Filed by the company against Asta Med Healthcare (I) Ltd. | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against Asta Med Healthcare (I) Ltd. | Disposed |
To see the full case history of Central Drug House Private Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Central Drug House Private Ltd has 6 MSME Form 1 returns on record between 2019 and 2024, listing 188 overdue payments to 97 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 97)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sulux Phosphates Ltd | |||
| Jyoti Som Chemicals | |||
| Shree J J Foam Industries | |||
| Shree Vishwa Pharma Chem | |||
| P J Enterprise |
To see the full MSME payment records of Central Drug House Private Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Central Drug House has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACC2523P1ZN | Delhi | Active | 01 Jul 2017 |
| 24AAACC2523P1ZR | Gujarat | Active | 01 Jul 2017 |
| 02AAACC2523P1ZX | Himachal Pradesh | Active | 08 Mar 2018 |
To see the full GST registrations and return filing status of Central Drug House Private Ltd, buy the company report.
Recent activity
Central Drug House Private Ltd has 7 board changes on record since 1985: 4 appointments and 3 cessations. The latest: Heena Sharma was appointed as Company Secretary on 06 Jan 2020.
4 earlier events are in the company report.
Frequently asked questions
Central Drug House is an active private limited company based in New Delhi, Delhi, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 06 March 1985 (41+ years old) and is registered under CIN U74899DL1985PTC020363.
Central Drug House has 3 current directors:
- Saurabh Aggarwal - Director
- Sachin Aggarwal - Director
- Shankar Lal Aggarwal - Director
The latest financial statements of Central Drug House on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Central Drug House is 07AAACC2523P1ZN, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACC2523P1ZR (Gujarat), 02AAACC2523P1ZX (Himachal Pradesh).
The CIN (Corporate Identification Number) of Central Drug House is U74899DL1985PTC020363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Central Drug House has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Central Drug House was incorporated on 06 March 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Central Drug House has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Cr; the latest was in March 2025.
The peers of Central Drug House by revenue are Ecmas Construction Chemicals Private Limited, Tarak Chemicals Limited, Galata Chemicals India Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Heena Sharma was appointed as Company Secretary on 06 Jan 2020. Saurabh Aggarwal ceased to be Additional Director on 28 Sep 2012. Saurabh Aggarwal was appointed as Director on 10 Feb 2012. Central Drug House has 7 board changes on record in total.
Yes, Central Drug House is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0000901).
Central Drug House has 6 MSME Form 1 returns on record between 2019 and 2024, listing 188 overdue payments to 97 micro and small suppliers. The latest return was filed on 30 Apr 2024.

